Order Article Reprints

Moore AM, Nooruddin Z, Reveles KR, Datta P, Whitehead JM, Franklin K, Alkadimi M, Williams MH, Williams RA, Smith S, et al. Durvalumab Treatment Patterns for Patients with Unresectable Stage III Non-Small Cell Lung Cancer in the Veterans Health Administration (VHA): A Nationwide, Real-World Study. Current Oncology. 2023; 30(9):8411-8423. https://doi.org/10.3390/curroncol30090611

Moore, Amanda M., Zohra Nooruddin, Kelly R. Reveles, Paromita Datta, Jennifer M. Whitehead, Kathleen Franklin, Munaf Alkadimi, Madison H. Williams, Ryan A. Williams, Sarah Smith, and et al. 2023. "Durvalumab Treatment Patterns for Patients with Unresectable Stage III Non-Small Cell Lung Cancer in the Veterans Health Administration (VHA): A Nationwide, Real-World Study" Current Oncology 30, no. 9: 8411-8423. https://doi.org/10.3390/curroncol30090611

Moore, A. M., Nooruddin, Z., Reveles, K. R., Datta, P., Whitehead, J. M., Franklin, K., Alkadimi, M., Williams, M. H., Williams, R. A., Smith, S., Reichelderfer, R., Cotarla, I., Brannman, L., Frankart, A., Mulrooney, T., Hsieh, K., Simmons, D. J., Jones, X., & Frei, C. R. (2023). Durvalumab Treatment Patterns for Patients with Unresectable Stage III Non-Small Cell Lung Cancer in the Veterans Health Administration (VHA): A Nationwide, Real-World Study. Current Oncology, 30(9), 8411-8423. https://doi.org/10.3390/curroncol30090611